Literature DB >> 29940767

Knockdown of long non-coding RNA PEG10 inhibits growth, migration and invasion of gastric carcinoma cells via up-regulating miR-3200.

J Wang1, X Q Chu1, D Zhang1, D F Kong1.   

Abstract

Gastric cancer is the main leading cause of cancer-related death worldwide. The aberrant expression of paternally expressed gene 10 (PEG10) is involved in development of a range of cancers. However, the potential biological function and the underling mechanism of PEG10 in human gastric carcinoma are still unknown. Knocking down LncRNA PEG10 might represent a promising therapeutic strategy for the treatment of gastric cancer. The expression of PEG10, miR-3200, and AEG1 in human gastric carcinoma NCI-N87 cells were altered by cell transfection assay. Cell viability, migration, invasion, and apoptosis were determined by trypan blue exclusion, Transwell assay, and flow cytometric analysis, respectively. RNA and protein expression level of gene was analyzed by real-time PCR and Western blot. Luciferase reporter assay was conducted to determine the target gene of miR-3200. JNK and Wnt signal pathway protein expressions were tested by Western blot. The up-regulation of PEG10 was found in clinical samples. PEG10 knockdown effectively inhibited gastric carcinoma cell viability, migration, and invasion, but promoted cell apoptosis. This tumor-suppressing effect of PEG10 knockdown might be realized by up-regulating miR-3200 in vitro and in vivo. AEG1 was a direct target gene of miR-3200. Moreover, miR-3200 might suppress NCI-N87 cells by negative regulating AEG1. Up-regulating miR-3200 effectively blocked JNK and Wnt pathways likely via down-regulating AEG1. PEG10 knockdown played a carcinostatic role via up-regulating miR-3200 and further regulating AEG1 in gastric carcinoma cells, during which process, JNK pathway and Wnt pathway were blocked.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29940767     DOI: 10.4149/neo_2018_171204N794

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  7 in total

1.  Silencing of Long Noncoding RNA LINC00324 Interacts with MicroRNA-3200-5p to Attenuate the Tumorigenesis of Gastric Cancer via Regulating BCAT1.

Authors:  Shuang Wang; Yuanyuan Cheng; Pingping Yang; Guang Qin
Journal:  Gastroenterol Res Pract       Date:  2020-08-13       Impact factor: 2.260

2.  An Immune-Related Prognostic Signature Predicts Overall Survival in Stomach Adenocarcinomas.

Authors:  Kangjie Zhou; Nan Hu; Yidong Hong; Xueyu Wu; Jingzhou Zhang; Huan Lai; Yang Zhang; Fenglei Wu
Journal:  Front Genet       Date:  2022-05-23       Impact factor: 4.772

3.  Prediction of relapse and prognosis by expression levels of long noncoding RNA PEG10 in glioma patients.

Authors:  Hui Xiao; Ning Ding; Hang Liao; Zhigang Yao; Xiankui Cheng; Jian Zhang; Miaoqing Zhao
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors.

Authors:  Joanna Boresowicz; Paulina Kober; Natalia Rusetska; Maria Maksymowicz; Agnieszka Paziewska; Michalina Dąbrowska; Natalia Zeber-Lubecka; Jacek Kunicki; Wiesław Bonicki; Jerzy Ostrowski; Janusz A Siedlecki; Mateusz Bujko
Journal:  Int J Endocrinol       Date:  2020-12-05       Impact factor: 3.257

5.  A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.

Authors:  Maoshu Zhu; Jiading Cai; Yulong Wu; Xinhong Wu; Lianghua Feng; Zhijiang Yin
Journal:  Med Sci Monit       Date:  2021-01-20

6.  Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.

Authors:  Zhizheng Liu; Hongliang Meng; Miaoxian Fang; Wenlong Guo
Journal:  J Healthc Eng       Date:  2021-11-20       Impact factor: 2.682

7.  Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.

Authors:  Przemysław A Stempor; Dror Avni; Raya Leibowitz; Yechezkel Sidi; Maria Stępień; Tomasz Dzieciątkowski; Paula Dobosz
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.